Lilly Needs Updated FDA Authorization To Sell COVID Antibody On Commercial Market

 
• By Sarah Karlin-Smith
Lilly office building
Dwindling government COVID funds shifts Lilly antibody sales to commercial market • Source: Shutterstock

More from United States

More from North America